CAR-NK cell therapy combined with checkpoint inhibition induces a NKT cell response in glioblastoma

被引：0
|
作者：
Strassheimer, Florian [1 ,2 ,3 ,4 ]
Elleringmann, Philipp [1 ,2 ,3 ,4 ]
Roller, Bastian [1 ,2 ,3 ,4 ]
Macas, Jadranka [2 ,5 ]
Alekseeva, Tijna [2 ,6 ]
Aliraj, Blerina [2 ,7 ]
Weber, Katharina [2 ,3 ,4 ,5 ]
Demes, Melanie [8 ]
Tonn, Torsten [9 ]
Reib, Yvonne [2 ,3 ,4 ,5 ]
Plate, Karl [2 ,3 ,4 ,5 ]
Weigert, Andreas [2 ,3 ,4 ,7 ]
Wels, Winfried [2 ,3 ,4 ,6 ]
Steinbach, Joachim [1 ,2 ,3 ,4 ]
Burger, Michael [1 ,2 ,3 ,4 ]
机构：
[1] Goethe Univ Frankfurt, Univ Hosp, Dr Senckenberg Inst Neurooncol, Frankfurt, Germany
[2] Goethe Univ Frankfurt, Frankfurt Canc Inst FCI, Frankfurt, Germany
[3] German Canc Consortium DKTK, Heidelberg, Germany
[4] German Canc Res Ctr, Heidelberg, Germany
[5] Goethe Univ Frankfurt, Univ Hosp, Inst Neurol, Edinger Inst, Frankfurt, Germany
[6] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, Frankfurt, Germany
[7] Goethe Univ Frankfurt, Inst Biochem 1, Frankfurt, Germany
[8] Goethe Univ Frankfurt, Univ Hosp, Dr Senckenberg Inst Pathol, Frankfurt, Germany
[9] Goethe Univ Frankfurt, Inst Transfus Med & Immune Hematol, German Red Cross Blood Donat Serv Baden Wurttembe, Frankfurt, Germany
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1921 - WS4
引用
收藏
页码：302 / 302
页数：1
相关论文
共 50 条
  • [21] Dual effect of epigenetic inhibitor and CAR-NK cell therapy in bladder cancer
    Morales, Lucia
    Nunes, Sandra Pinto
    Munera-Maravilla, Ester
    Casado, Jose Antonio
    Rio, Paula
    Valeri, Antonio
    Jose-Eneriz, Edurne San
    Agirre, Xavier
    Prosper, Felipe
    Paramio, Jesus Maria
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [22] CAR-NK cell in cancer immunotherapy; A promising frontier
    Marofi, Faroogh
    Abdul-Rasheed, Omar F.
    Rahman, Heshu Sulaiman
    Budi, Hendrik Setia
    Jalil, Abduladheem Turki
    Yumashev, Alexei Valerievich
    Hassanzadeh, Ali
    Yazdanifar, Mahboubeh
    Motavalli, Roza
    Chartrand, Max Stanley
    Ahmadi, Majid
    Cid-Arreguid, Angel
    Jarahian, Mostafa
    CANCER SCIENCE, 2021, 112 (09) : 3427 - 3436
  • [23] Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
    Albinger, Nawid
    Hartmann, Jessica
    Ullrich, Evelyn
    GENE THERAPY, 2021, 28 (09) : 513 - 527
  • [24] Characterization of anti-AXL CAR-NK cell therapy for the treatment of melanoma
    Hibler, Winston
    Merlino, Glenn
    Yu, Yan Lin
    CANCER RESEARCH, 2024, 84 (06)
  • [25] Assessing the cytotoxic potential of novel CAR-NK cells targeting glioblastoma stem cell antigens
    Lima, Vitoria A.
    Mitsugi, Thiago G.
    Okamoto, Oswaldo K.
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [26] A universal CAR-NK cell approach for HIV eradication
    Arachchige, Arosh S. Perera Molligoda
    AIMS ALLERGY AND IMMUNOLOGY, 2021, 5 (03): : 192 - 194
  • [27] CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma
    Tingdang Liu
    Ximing Dai
    Yien Xu
    Tian Guan
    Liangli Hong
    Tahir Zaib
    Qi Zhou
    Ke Cheng
    Xiaoling Zhou
    Changchun Ma
    Pingnan Sun
    Journal of Translational Medicine, 21
  • [28] CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma
    Liu, Tingdang
    Dai, Ximing
    Xu, Yien
    Guan, Tian
    Hong, Liangli
    Zaib, Tahir
    Zhou, Qi
    Cheng, Ke
    Zhou, Xiaoling
    Ma, Changchun
    Sun, Pingnan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [29] Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
    Dehghan, Fatemeh
    Metanat, Yekta
    Askarizadeh, Mandana
    Ahmadi, Ehsan
    Moradi, Vahid
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2025, 12
  • [30] CAR-NK cell therapy for hematological malignancies: recent updates from ASH 2022
    Huang, Ruihao
    Wen, Qin
    Zhang, Xi
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
12345